Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wijnhoven BPL et al. – The current data on neoadjuvant chemoradiation for esophageal cancer strongly indicate the need for designing future high–quality trials that will contribute to a better understanding of the role of neoadjuvant treatment for resectable cancer of the esophagus and help to identify patient subgroups that would benefit most.

Related Articles

Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma
Lipids in Health and Disease, 10/30/09    Relevance Score: 66%

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
Annals of Surgical Oncology, 10/20/09    Relevance Score: 66%

Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer
Surgery Today, 10/06/09    Relevance Score: 66%

The high incidence of esophageal cancer in parts of China may result primarily from genetic rather than environmental factors
Diseases of the Esophagus, 11/10/09    Relevance Score: 65%

Pilot study on confocal endomicroscopy for determination of the depth of squamous cell esophageal cancer in vivo
Journal of Gastroenterology and Hepatology, 10/29/09    Relevance Score: 65%

Today in Stomach/GI...keeping you current

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address